Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M451Revenue $M36.4Net Margin (%)0.1Altman Z-Score34.8
Enterprise Value $M338EPS $--Operating Margin %-1.5Piotroski F-Score5
P/E(ttm)--Beneish M-Score25.5Pre-tax Margin (%)0.1Higher ROA y-yY
Price/Book3.210-y EBITDA Growth Rate %--Quick Ratio17.5Cash flow > EarningsN
Price/Sales12.75-y EBITDA Growth Rate %--Current Ratio17.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)0.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)0.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M159ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with GERN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GERNJoel Greenblatt 2015-12-31 Buy 0.02%$2.91 - $5.12
($4.06)
$ 2.84-30%New holding299,986
GERNFirst Eagle Investment 2015-12-31 Reduce$2.91 - $5.12
($4.06)
$ 2.84-30%Reduce -3.04%159,700
GERNFirst Eagle Investment 2015-06-30 Reduce-0.01%$3.62 - $4.33
($3.96)
$ 2.84-28%Reduce -77.40%164,700
GERNFirst Eagle Investment 2015-03-31 Reduce$2.81 - $4.34
($3.39)
$ 2.84-16%Reduce -35.43%728,866
GERNFirst Eagle Investment 2014-12-31 Reduce-0.01%$1.85 - $3.84
($2.78)
$ 2.842%Reduce -48.64%1,128,866
GERNFirst Eagle Investment 2014-09-30 Reduce-0.01%$2.12 - $3.014
($2.46)
$ 2.8415%Reduce -38.05%2,198,124
GERNFirst Eagle Investment 2014-03-31 Add0.01%$1.6 - $5.4
($4.04)
$ 2.84-30%Add 46.43%3,054,252
GERNFirst Eagle Investment 2013-03-31 Add$1.01 - $1.64
($1.38)
$ 2.84106%Add 36.91%2,410,934
GERNGeorge Soros 2011-03-31 Sold Out $4.44 - $5.07
($4.71)
$ 2.84-40%Sold Out0
GERNFirst Eagle Investment 2010-12-31 Add0.03%$4.46 - $6.02
($5.23)
$ 2.84-46%Add 74.80%2,570,500
GERNGeorge Soros 2010-12-31 Buy $4.46 - $6.02
($5.23)
$ 2.84-46%New holding26,500
GERNFirst Eagle Investment 2010-06-30 Add0.02%$4.67 - $5.81
($5.13)
$ 2.84-45%Add 77.56%1,420,500
GERNFirst Eagle Investment 2010-03-31 Add0.03%$4.97 - $6.21
($5.58)
$ 2.84-49%Add 204.80%800,000
GERNFirst Eagle Investment 2009-12-31 Add0.02%$4.91 - $6.69
($5.55)
$ 2.84-49%Add 556.18%262,471
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GERN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GERN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BEHRS MELISSA KELLYEVP BD and Port&Alliance Mgmt 2015-05-29Sell2,380$3.84-26.04view
Bloom Olivia KyusukEVP, CFO 2015-05-29Sell2,380$3.84-26.04view
Hofstaetter ThomasDirector 2015-03-18Sell70,000$4.1-30.73view
Bloom Olivia KyusukEVP, CFO 2014-05-29Sell3,379$2.135.24view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-05-29Sell4,826$2.135.24view
BRADBURY DANIELDirector 2014-05-09Buy142,776$1.7562.29view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-04-01Sell12,310$2.1333.33view
Bloom Olivia KyusukEVP, CFO 2014-04-01Sell7,435$2.1333.33view
SCARLETT JOHN APresident and CEO 2013-04-01Buy50,000$1.03175.73view
BEHRS MELISSA KELLYSVP Alliance and Prog Mgmt 2013-01-17Sell28,292$1.6572.12view

Quarterly/Annual Reports about GERN:

News about GERN:

Articles On GuruFocus.com
Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
WEEKLY CFO SELLS HIGHLIGHT: HTM, OVTI, VSEA, KSWS,GERN, ATRC Jun 20 2011 
Geron Corp. Reports Operating Results (10-Q) Oct 29 2010 
Geron: Buyer Beware Oct 13 2010 
Geron Corp. (GERN) President and CEO Thomas Okarma sells 18,874 Shares Jun 03 2010 
Geron Corp. (GERN) EVP and CFO David Greenwood sells 14,746 Shares Jun 03 2010 
Banking 60% on the Day the World Changed: FDA Approves Geron to Test Embryonic Stem Cells on Humans Jan 24 2009 
The Next Boom Emerges Nov 23 2008 

More From Other Websites
Geron (GERN) Q1 Earnings: What's in Store for the Stock? May 03 2016
Geron Announces Conference Call to Discuss First Quarter 2016 Financial Results Apr 27 2016
Geron Announces Conference Call to Discuss First Quarter 2016 Financial Results Apr 27 2016
Why one trader is buying puts in Geron Apr 21 2016
Geron Announces Two Imetelstat Poster Presentations at the American Association for Cancer Research... Apr 20 2016
Geron Announces Two Imetelstat Poster Presentations at the American Association for Cancer Research... Apr 20 2016
Geron to Present at the Needham Healthcare Conference Apr 05 2016
Geron to Present at the Needham Healthcare Conference Apr 05 2016
Why Investors Are So Bullish on This Small Biotech Mar 30 2016
The Zacks Analyst Blog Highlights: Corcept Therapeutics, Epizyme, Geron and Synthetic Biologics Mar 29 2016
Geron Corp. – Value Analysis (NASDAQ:GERN) : March 23, 2016 Mar 23 2016
GERON CORP Financials Mar 22 2016
Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : March 22, 2016 Mar 22 2016
Geron Announces Presentations at American Association of Cancer Research Annual Meeting Mar 17 2016
GERON CORP Files SEC form 10-K, Annual Report Mar 10 2016
The Biotech Bull Market Is Back Mar 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)